Who should get what slice of the pie once the medicine is available in public clinics? And are numbers alone what would drive decisions?
None of the companies that will be involved have a licence from the inventor of Lenacapavir, Gilead Sciences, to make the jab
The country’s medicines regulator Sahpra says it’s on track to announce its registration decision by the end of October
Hetero and Dr Reddy’s will be funded by the Gates Foundation and Unitaid to produce and sell the twice-a-year anti-HIV shot around R692 per person a year
If we create one system, we could start seeing as many new products as research papers, and as many new jobs as there are journal articles
The health department hopes to make the twice-a-year anti-HIV injection lenacapavir available soon and to be buying generics by 2027
The country isn’t getting extra money from the Global Fund to Fight Aids, TB and Malaria; it has to use cash from a grant it has already been awarded and was cut by 16% in June
There is an urgent need to prevent the proliferation of counterfeit and substandard pharmaceuticals
Attention deficit and hyperactivity disorder affects 5% to 7% of schoolgoing children, but doctors can only prescribe treatment for a month at a time, so don’t get too much…
Enabling the use of generics, supporting local businesses and setting up a state pharmaceutical company would boost healthcare
An inter-referral system between conventional and complementary medical practitioners is essential to giving patients optimal care in our diverse society
New legislation could be brought before parliament in the coming session
Almost 5% of the world’s carbon emissions come from the healthcare sector. Rethinking how hospitals run can get this down. But healthcare workers say regulations stop them from…
The production of cannabis and hemp for medicinal and industrial purposes finally gets a boost from the government
Five years after being told to fix South Africa’s unconstitutional cannabis laws, the state has failed to do so
